DHODH and cancer: Several other inhibitors of DHODH have been investigated for the treatment of cancer, these include brequinar, leflunomide, its active metabolite teriflunomide, IMU-383 (vidofludimus), BAY 2402234, and ASLAN003 (18, 36, 40–44).